Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp

Journal of Infection in Developing Countries

Volumn 7, Issue 11, 2013, Pages 880-887

  Mohanty, Srujana ^a   Maurya, Vijeta ^a   Gaind, Rajni ^a   Deb, Monorama ^a  

^a SAFDARJUNG HOSPITAL   (India)

Author keywords

Acinetobacter spp.; Carbapenem resistance; Colistin susceptibility and MIC; Metallo lactamase; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; CARBAPENEM; CEFOPERAZONE PLUS SULBACTAM; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; NETILMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; DISK DIFFUSION; EPSILOMETER TEST; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PREVALENCE; PSEUDOMONAS AERUGINOSA; TEACHING HOSPITAL;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; COLISTIN; HUMANS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84887584041     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.2924     Document Type: Article

References (38)

1. Endimiani A, Luzzaro F, Pini B, Amicosante G, Rossoloni GM, Toniolo AQ (2006) Pseudomonas aeruginosa bloodstream infections: Risk factors and treatment outcome related to expression of the PER-1 extended-spectrum beta-lactamase. BMC Infect Dis 6: 52.
2. Deris ZZ, Harun A, Shafei MN, Rahman RA, Johari MR (2009) Outcomes and appropriateness of management of nosocomial Acinetobacter bloodstream infections at a teaching hospital in northeastern Malaysia. Southeast Asian J Trop Med Public Health 40: 140-147.
3. Navon-Venezia S, Ben-Ami R, Carmeli Y (2005) Update on Pseudomonas aeruginosa and Acinetobacter baumanii infections in the healthcare setting. Curr Opin Infect Dis 18: 306-313.
4. Jones RN, Biedenbach DJ, Sader HS, Fritsche TR, Toleman MA, Walsh TR (2005) Emerging epidemic of metallo-β-lactamase -mediated resistances. Diagn Microbiol Infect Dis 51: 77-84.
5. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA (2007) Global challenge of multi drug resistant Acinetobacter baumannii. Antimicrob Agents Chemother 51: 3471-3484.
6. Manchanda V, Sachaita S, Singh NP (2010) Multi drug resistant Acinetobacter. J Global Infect Dis 2: 291-304.
7. Turner PJ, Greenhalgh JM (2003) MYSTIC Study Group (Europe) The activity of meropenem and comparators against Acinetobacter strains isolated from European hospitals, 1997-2000. Clin Microbiol Infect 9: 563-567.
8. Turner PJ (2008) Meropenem activity against European isolates: report on the MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) 2006 results. Diagn Microbiol Infect Dis60: 185-192.
9. Baumgart AM, Molinari MA, Silveira AC (2010) Prevalence of carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumanii in high complexity hospital. Braz J Infect Dis 14: 433-436.
10. Shashikala, Kanungo R, Srinivasan S, Devi S (2006) Emerging resistance to carbapenems in hospital acquired Pseudomonas infection: a cause for concern. Indian J Pharmacol 38: 287-288.
11. Behera B, Das A, Mathur P, Kapil A (2008) High prevalence of carbapenem resistant Pseudomonas aeruginosa at a tertiary care centre of North India. Are we under-reporting? Indian J Med Res 128: 324-325.
12. Gaur A, Garg A, Prakash P, Anupurba S, Mohapatra TM (2008) Observations on carbapenem resistance by minimum inhibitory concentration in nososcomial isolates of Acinetobacter species: an experience at a tertiary care hospital in North India. J Health Popul Nutr 26: 183-188.
13. Uma Karthika R, Srinivasa Rao R, Sahoo S, Shashikala P, Kanungo R, Jayachandran S, Prashanth K (2009) Phenotypic and genotypic assays for detecting the prevalence of metallo-β-lactamases in clinical isolates of Acinetobacter baumanii from a South Indian tertiary care hospital. J Med Microbiol 58: 430-435.
14. Roy S, Basu S, Dasgupta S, Singh AK, Viswanathan R (2010) Carbapenem resistance in Acinatobacterbaumanii isolated from blood of neonates with sepsis. Indian J Med Microbiol 28: 416-417.
15. Amin NE, Giske CG, Jala S, Keijser B, Kronvall G, Wretlind B (2005) Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates. APMIS 113: 187-196.
16. Durante-Mangnoni E, Zarrilli R (2011) Global spread of drug-resistant Acinetobacter baumanii: molecular epidemiology and management of antimicrobial resistance. Future Microbiol 6: 407-422.
17. Bonomo RA, Szabo D (2006) Mechanisms of multidrug resistance in Acinetobactter species and Pseudomonas aeruginosa. Clin Infect Dis 43: 549-556.
18. Li J, Nation RL, Turnidge JD, et al (2006) Colistin: the re-emerging antibiotic for multidrug- resistant Gram-negative bacterial infections. Lancet 6: 589-601.
19. Hemlatha V, Sekar U, Kamat V (2005) Detection of metallo-beta-lactamase producing Pseudomonasaeruginosa in hospitalized patients. Indian J Med Res 122: 148-152.
20. Varaiya A, Kulkarni M, Bhalekar P, Dogra J (2008) Incidence of metallo-beta-lactamse-producing Pseudomonas aeruginosa in diabetes and cancer patients. Indian J Pathol Microbiol 51: 200-203.
21. Noyal MJC, Menezes GA, Harish BN, Sujatha S, Parija SC (2009) Simple screening tests for detection of carbapenemases in clinical isolates of nonfermentative Gram-negative bacteria. Indian J Med Res 129: 707-712.
22. John S, Balagurunathan R (2011) Metallo beta lactamase producing Pseudomonas aeruginosa and Acinetobacter baumanii. Indian J Med Microbiol 29: 302-304.
23. Taneja N, Singh G, Singh M, Sharma M (2011) Emergence of tigecycline & colistin resistant Acinetobacter baumanii in patients with complicated urinary tract infections in north India. Indian J Med Res 133: 681-684.
24. th ed. Edinburgh: Churchill Livingstone p. 131-150.
25. Clinical and Laboratory Standards Institute (2011) Performance standards for antimicrobial susceptibility testing. Approved Standards; Twenty-first Informational Supplement; CLSI document M100-S21.CLI: Wayne, PA.
26. Magiorakos AP, Srinivasan A, Carey RB, Carmete Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multi drug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18: 268-281.
27. Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y (2002) Imipenem- EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 40: 3798-3801.
28. Brink A, Moolman J, da Silva MC, Botha M (2007) National Antibiotic Surveillance Forum. Antimicrobial susceptibility profile of selected bacteraemic pathogens from private institutions in South Africa. South Afr Med J 97: 273-279.
29. Irfan S, Idrees F, Mehraj V, Habib F, Adil S, Hasan R (2008) Emergence of carbapenem resistant gram negative and vancomycin resistant gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study. BMC Infect Dis 8: 80-85.
30. Wareham DW, Bean DC, Khanna P, Hennessy EM, Krahe D, Ely A, Millar M (2008) Bloodstream infection due to Acinetobacter spp.: epidemiology, risk factors and impact of multi-drug resistance. Eur J Clin Microbiol Infectious Dis 27: 607-612.
31. Navaneeth BV, Sridaran D, Sahay D, Belwadi MR (2002) A preliminary study on metallo-β-lactamase producing Pseudomonas aeruginosa in hospitalized patients. Indian J Med Res 116: 264-267.
32. Agrawal G, Lodhi RB, Kamalakar UP, Khadse RK, Jalgaonkar SV (2008) Study of metallo-β-lactamase production in clinical isolates of Pseudomonas aeruginosa. Indian J Med Microbiol 26: 349-351.
33. Tan TY, Ng SY (2006) The in vitro activity of colistin in gram-negative bacteria. Singapore Med J 47: 621-624.
34. Pit TL, Sparrow M, Warner M, Stefanidou M (2003) Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents. Thorax 58: 794-796.
35. Manoharan A, Chatterjee S, Mathai D, SARI Study Group (2010) Detection and characterization of metallo beta lactamases producing Pseudomonas aeruginosa. Indian J Med Microbiol 28: 241-244.
36. Shanthi Amudhan M, Sekar U, Kamalanathan A, Balaraman S (2012)blaIMP and blaVIM mediated carbapenem resistance in Pseudomonas and Acinetobacter species in India. J Infect Dev Ctries 6: 757-762.
37. Purohit M, Mendiratta DK, Deotale VS, Madhan M, Manoharan A, Naranag P (2012) Detection of metallo-β-lactamases producing Acinetobacter baumanii using microbiological assay, disc synergy test and PCR. Indian J Med Microbiol 30: 456-461.
38. Amudhan SM, Sekar U, Arunagiri K, Sekar B (2011) Oxa-beta-lactamase mediated carbapenem resistance in Acinetobacter baumanii. Indian J Med Microbiol 29: 269-274.